New drug shows promise in fighting obesity in major trial
NCT ID NCT04904913
Summary
This study tested an experimental weekly injection called IBI362 to see if it helps people lose weight. It involved 328 overweight or obese adults in China who also followed a diet and exercise plan. Researchers compared several doses of the drug against a placebo (a dummy treatment) to measure changes in body weight and other health markers over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT , OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University people's hospital
Beijing, Beijing Municipality, 100044, China
Conditions
Explore the condition pages connected to this study.